SE8206073L - Tumoravbildning med radiomerkta monoklonala antikroppar - Google Patents

Tumoravbildning med radiomerkta monoklonala antikroppar

Info

Publication number
SE8206073L
SE8206073L SE8206073A SE8206073A SE8206073L SE 8206073 L SE8206073 L SE 8206073L SE 8206073 A SE8206073 A SE 8206073A SE 8206073 A SE8206073 A SE 8206073A SE 8206073 L SE8206073 L SE 8206073L
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
tumor imaging
radiolabeled monoclonal
tumour
antibody
Prior art date
Application number
SE8206073A
Other languages
Unknown language ( )
English (en)
Other versions
SE8206073D0 (sv
Inventor
T H Adams
G S David
S E Halpern
Original Assignee
Hybritech Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc, Univ California filed Critical Hybritech Inc
Publication of SE8206073D0 publication Critical patent/SE8206073D0/sv
Publication of SE8206073L publication Critical patent/SE8206073L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1066—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8206073A 1981-10-27 1982-10-26 Tumoravbildning med radiomerkta monoklonala antikroppar SE8206073L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31528681A 1981-10-27 1981-10-27

Publications (2)

Publication Number Publication Date
SE8206073D0 SE8206073D0 (sv) 1982-10-26
SE8206073L true SE8206073L (sv) 1983-04-28

Family

ID=23223718

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8206073A SE8206073L (sv) 1981-10-27 1982-10-26 Tumoravbildning med radiomerkta monoklonala antikroppar

Country Status (18)

Country Link
JP (1) JPS58135820A (sv)
AT (1) AT392004B (sv)
BE (1) BE894829A (sv)
CA (1) CA1202892A (sv)
CH (1) CH653040A5 (sv)
DE (1) DE3239410A1 (sv)
DK (1) DK164682C (sv)
ES (2) ES516797A0 (sv)
FI (1) FI82379C (sv)
FR (1) FR2515046B1 (sv)
GB (1) GB2109407B (sv)
IL (1) IL67068A0 (sv)
IT (1) IT1153857B (sv)
LU (1) LU84441A1 (sv)
NL (1) NL8204108A (sv)
NO (1) NO169947C (sv)
SE (1) SE8206073L (sv)
ZA (1) ZA827806B (sv)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
CA1225930A (en) * 1982-06-07 1987-08-25 Otto A. Gansow Metal chelate conjugated monoclonal antibodies
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
SE8401946L (sv) * 1983-04-08 1984-11-13 Kureha Chemical Ind Co Ltd Antikropp mot human prostatacancer
GB2140030A (en) * 1983-04-08 1984-11-21 Kureha Chemical Ind Co Ltd Monoclonal antibody to human urinary bladder cancer
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
CA1340014C (en) * 1986-10-27 1998-08-25 Bryan Michael Longenecker Carcinoma-marking monoclonal antibodies elicited with synthetic asialo-gmi antigen
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US4838274A (en) * 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5217704A (en) * 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US7521531B2 (en) 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US6558669B1 (en) * 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers

Also Published As

Publication number Publication date
FI823633L (fi) 1983-04-28
DE3239410A1 (de) 1983-05-19
NL8204108A (nl) 1983-05-16
IT8223932A0 (it) 1982-10-26
ES8404857A1 (es) 1984-05-16
FR2515046A1 (fr) 1983-04-29
JPH0564130B2 (sv) 1993-09-14
NO169947B (no) 1992-05-18
ES529310A0 (es) 1985-05-16
ATA391682A (de) 1990-07-15
LU84441A1 (fr) 1983-06-13
FI823633A0 (fi) 1982-10-25
NO823530L (no) 1983-04-28
IL67068A0 (en) 1983-02-23
BE894829A (fr) 1983-02-14
IT1153857B (it) 1987-01-21
GB2109407A (en) 1983-06-02
CH653040A5 (de) 1985-12-13
FI82379B (fi) 1990-11-30
DK474182A (da) 1983-04-28
GB2109407B (en) 1985-12-18
ES8505482A1 (es) 1985-05-16
AT392004B (de) 1991-01-10
DK164682B (da) 1992-08-03
JPS58135820A (ja) 1983-08-12
ES516797A0 (es) 1984-05-16
FR2515046B1 (fr) 1985-11-29
DE3239410C2 (sv) 1991-12-19
CA1202892A (en) 1986-04-08
DK164682C (da) 1992-12-21
FI82379C (sv) 1991-03-11
NO169947C (no) 1992-08-26
SE8206073D0 (sv) 1982-10-26
ZA827806B (en) 1983-08-31

Similar Documents

Publication Publication Date Title
SE8206073L (sv) Tumoravbildning med radiomerkta monoklonala antikroppar
ZA805813B (en) Composition and method for cancer detection in humans
Colcher et al. Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody
ZA879076B (en) Detection of necrotic malignant tissue and associated therapy
EP0778849A4 (en) POLYSPECIFIC IMMUNO-CONJUGATES AND ANTIBODY-COMPOSITE MOLECULES FOR THE TARGETED DETECTION OF THE DIFFERENT MEDICINE-RESISTANT PHENOTYPS
DE3588210D1 (de) Biologisch nützliche Konjugate
DE3578625D1 (de) Radioaktiv markierte antikoerperstuecke.
GB8519457D0 (en) Tumour imaging agents
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
KR920700690A (ko) α-입자 방출을 이용하는 방사선 면역치료제
ES445768A1 (es) Metodo de preparacion de un reactivo en fase solida para usoen el radio inmunoensayo de antigenos y anticuerpos y de realizacon del radio inmunoensayo.
Bernhard et al. Localization of 111In-and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors
SE7508003L (sv) Forfarande for pavisning av gonorreantikroppar
EP0327389A3 (en) Tumour imaging
Mohd FRAGMENTATION, LABELING AND BIODISTRIBUTION STUDIES OF KS1/4, A MONOCLONAL ANTIBODY.
Line Localization of 111In-and 125I-labeled Monoclonal Antibody in
NL7609853A (en) Neoplasms immunological diagnosis - using cancer antigen NEA or its antibodies (NL070377)
Line I-labeled Monoclonal Antibody in 125 In-and 111 Localization of
McQuarrie The development of a pharmacokinetic and radiation dosimetric model for selected technetium-99m labelled monoclonal antibodies.
JPS52151725A (en) Diagnostic reagent for neoplasm
Alvarez-Cervera et al. Preparation, labelling, and use of albumin microspheres
FR2025062A1 (en) Cancer-diagnostic prepn
JPS57163319A (en) Preparation of antibody

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8206073-2

NAV Patent application has lapsed

Ref document number: 8206073-2